Additionally, when examining CELF1 expression in breast cancer cells at both transcriptional and protein levels, we observed a pronounced upregulation specifically in luminal breast cancer cells, as opposed to HER2-positive cells (Figures 3D–G; Supplementary Figure S2C). This evidence concerns the gene ERBB2 and breast carcinoma.